EPAS1 and neuroblastoma: Nuclear immunoreactivity of HIF1α coincided with that of HIF2α in all neuroblastoma xenografts (Fig. 4, Table 2), albeit with lower intensity which was particularly evident in tumors derived from Kelly cells.